Devin Traynor
Medical · Hagerstown, MDNPI 1194919795
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 454 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Amgen at 27.1% of the total. Among medical clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 454 payments — averaging $21.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$3K
- AbbVie$1K
- Johnson & Johnson$1K
- AstraZeneca$1K
- UCB, Inc.$1K
- Novartis$484
- plus $2K from 19 others
What the payments were for
- Food & beverage$9,63599%
- Education$711%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 115 | $2,627 |
| AbbVie | 103 | $1,445 |
| Johnson & Johnson(2 entities) | 40 | $1,150 |
| AstraZeneca | 55 | $1,142 |
| UCB, Inc. | 50 | $1,037 |
| Novartis | 9 | $484 |
| GSK | 16 | $351 |
| Mallinckrodt Hospital Products Inc. | 14 | $310 |
| E.r. Squibb & Sons, L.L.C. | 12 | $204 |
| Sobi, Inc | 2 | $177 |
| Radius Health, Inc. | 7 | $161 |
| Lilly USA, LLC | 8 | $145 |
| Fresenius Kabi USA, LLC | 4 | $93 |
| Sanofi | 3 | $67 |
| Aurinia Pharma U.S., Inc. | 2 | $47 |
| Pacira Pharmaceuticals Incorporated | 2 | $40 |
| ANI Pharmaceuticals, Inc. | 2 | $37 |
| Boehringer Ingelheim | 2 | $37 |
| Boston Scientific | 1 | $33 |
| Hikma Pharmaceuticals USA | 2 | $32 |
| Scilex Pharmaceuticals Inc. | 1 | $24 |
| Pfizer | 1 | $20 |
| Sandoz | 1 | $18 |
| Genentech USA, Inc. | 1 | $15 |
| Antares Pharma, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,706 in reported general payments places this provider in the 90th percentile of 543 medical providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 50 | $542,013 |
| OtezlaApremilast | 73 | $305,771 |
| Humira(Cf)Adalimumab | 19 | $255,246 |
| Enbrel SureclickEtanercept | 18 | $190,600 |
| Humira PenAdalimumab | 13 | $88,550 |
| Cimzia (2 Pack)Certolizumab Pegol | 11 | $61,904 |
| Hydroxychloroquine Sulfate | 373 | $18,517 |
| MethotrexateMethotrexate Sodium | 307 | $10,083 |
| Colchicine | 79 | $9,677 |
| Leflunomide | 74 | $5,121 |
| Celecoxib | 77 | $5,084 |
| Duloxetine Hcl | 103 | $2,619 |
| Prednisone | 217 | $2,495 |
| Sulfasalazine | 40 | $1,382 |
| Diclofenac Sodium | 30 | $1,188 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenOtezla | $2,627 | $305,77173 claims |
| AbbVieHumira(Cf) | $1,445 | $255,24619 claims |
| UCB, Inc.Cimzia (2 Pack) | $1,037 | $61,90411 claims |
| Scilex Pharmaceuticals Inc.Colchicine | $24 | $9,67779 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 543 medical providers in Maryland.
Other medical in Hagerstown
- Cheri CartagenaHagerstown$14K
- Victoria TrottStevensville$94K
- Sarah SagorskyBaltimore$68K
- Emily GrisnikLeonardtown$62K
- Jennifer HamiltonBel Air$52K
- Kristina TrunnellFrederick$51K
- Karen ScottAnnapolis$49K
- Nicholas WunderAberdeen$40K
- Sarah JamiesonFrederick$34K
- Jayme WilliamsCatonsville$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.